Financing, Equity Capital Markets

Kiadis Pharma B.V.

05/19
|
$31.2 Million
Piper Sandler served as bookrunner for Kiadis Pharma on a confidentially marketed follow-on offering
Sub-Type
CMFO
Sub-Sector
Biopharma